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Abstract
Objectives The objectives of this article are to review and
illustrate the imaging appearances of haematological malig-
nancies in the breast.
Methods With Institutional Review Board approval, a search
of the surgical pathology records from 1st January 2000 to 1st
July 2012 was performed for haematological malignancies.
Results Forty-eight cases of haematological malignancies
(42 women and 6 men) were identified with imaging
available for review: 39 cases of breast lymphoma, 6 cases
of chronic lymphocytic leukaemia, 2 cases of acute leukaemia
and 1 case of known multiple myeloma.
Conclusions Breast manifestations of haematological malig-
nancies are rare. They can have a variable appearance at
imaging and can mimic primary breast carcinoma. In the
setting of suspicious breast imaging findings, pathological
diagnosis of haematological malignancy is concordant. Cor-
relation with a clinical history of prior haematological malig-
nancy can be helpful in suggesting the diagnosis and help
prevent unnecessary surgical treatment.
Teaching Points
• Breast haematological malignancies are rare but the imaging
appearances can mimic breast carcinoma.
• Breast lymphoma, most often B-cell non-Hodgkin lympho-
ma, may be primary or due to secondary disease.
• At ultrasound, haematological malignancies may present as
a heterogeneous or predominantly echogenic mass.
•Haematological malignancies show intense activity on PET/
CT except myeloma which has low FDG uptake.
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Introduction
Haematological malignancies are common, accounting for
approximately 9 % of new cancer diagnoses in the United
States in 2013 [1]. However, manifestations of these malig-
nancies in the breast are rare [2]. A prior history of haemato-
logical malignancy may be helpful in diagnosing secondary
breast lesions; however, the breast presentation may be the
initial diagnosis of a systemic process [3]. The purpose of this
article is to review the imaging findings of haematological
malignancies in the breast which can mimic primary breast
cancer.
With Institutional Review Board approval, a search of
surgical pathology records of approximately 12,000 breast
biopsies performed at our institution from 1st January 2000
to 1st July 2012 yielded 48 cases of haematological malig-
nancies; 39 cases of breast lymphoma (19 representing
primary lymphoma and 20 with known secondary lympho-
ma, median age 66 years, range 30–89 years), 6 cases of
chronic lymphocytic leukaemia (4 representing a new diag-
nosis and 2 with known chronic lymphocytic leukaemia
[CLL], median age 68 years, range 62–76 years), 2 cases
of acute leukaemia (1 representing a new diagnosis and 1
with known leukaemia, ages 31 and 83 years) and 1 case
of known multiple myeloma (age 57 years). The majority
of patients presented with palpable findings on self or
clinical breast examination (n=40); the remaining patients
having a lesion identified at screening mammography or
incidentally found on computed tomography (CT). Themajority
of cases were female (42 women and 6 men). Mammograms
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were available in 45 patients and breast ultrasound in 46 pa-
tients. Positron emission tomography/computed tomography
(PET/CT) images were also available for six patients. None of
the patients received a dedicated breast magnetic resonance
imaging (MRI) examination, presumably because diagnosis of
haematological malignancy (via image-guided percutaneous
biopsy) negated the need for this form of advanced imaging.
All imaging studies were reviewed by fellowship-trained radi-
ologists specialising in breast imaging and intervention (K.G.,
R.F., S.Z., K.J.). Here we review and illustrate the salient
imaging features of haematological malignancies in the breast.
Breast lymphoma
Breast lymphoma (BL) may occur as either a primary breast
tumour or as an extranodal manifestation of secondary dis-
ease. By definition, primary breast lymphoma first manifests
in the breast without evidence of lymphoma elsewhere, except
ipsilateral axillary and supraclavicular lymph nodes [2, 4].
Additionally, there should be no prior history of lymphoma.
Extranodal disease refers to lymphomatous involvement of
tissues other than lymph nodes. Almost any organ can be
affected; however, common extranodal sites include the
stomach, Waldeyer ring, central nervous system, lung,
bone and skin [5].
Primary breast lymphoma accounts for 0.85–2.2 % of all
extranodal lymphomas and 0.1–0.5 % of breast neoplasms
[6, 7]. Secondary lymphoma is slightly more common than
primary lymphoma. The World Health Organisation classi-
fication for breast tumours subdivides lymphomas of the
breast into diffuse large cell lymphoma, Burkitt lymphoma,
extranodal marginal-zone B-cell lymphoma of MALT type
and follicular lymphoma. Primary breast lymphomas are
usually non-Hodgkin type with B-cell lineage [8]. Some
forms of T-cell lymphoma are more common in Asia than
in Western countries [2].
Clinically, BL most commonly presents as enlarging, pain-
less breast mass(es), although pain can be present in up to
25 % of cases. Less common presentations include nipple
retraction or discharge and diffuse skin thickening and oede-
ma, mimicking inflammatory breast cancer [8]. Burkitt lym-
phoma is more common in black women and may present as
massive, bilateral breast enlargement [8]. B type symptoms of
sweating, weight loss and fever are rare in primary BL but
more commonly noted in patients with secondary BL. Age
range can be wide but the median age is 55–65 years [8, 9]. In
our series there was a wide age range (30–89 years) with a
median age of 66 years.
Mammography
BLmay be identified incidentally on screening mammograms
[7, 8]. Solitary non-calcified masses represent the most com-
mon reported mammographic finding in BL [6, 7]. Lesions
may be bilateral in up to 28 % [6]. Margin analysis is less
consistent. In a contemporary series reported by Surov et al.
[6], margins were circumscribed in 66% of cases, lobulated in
30 % and indistinct in 3 %. However, indistinct margins were
noted in 72 % of cases in a series reported by Yang et al. [8].
Spiculated margins are rarely demonstrated. BL presenting as
architectural distortion is also rare. In our series, approximate-
ly half of all BL cases represented irregular masses with
indistinct margins (Fig. 1), and one-third demonstrated
circumscribed margins (Figs. 2 and 3). Four cases presented
as a developing asymmetry (Fig. 4), and one case as architec-
tural distortion. Diffuse infiltration by lymphomatous deposits
may also occur but may be obscured at mammography in
patients with dense breast tissue. Ipsilateral axillary nodal
involvement has been shown to be present in more than
40 % of patients with primary BL, although this was seen
in only 3/19 (16 %) of our cases. The size of primary BL
lesions range from 1 to 5 cm in Yang et al.’s series with
Fig. 1 A 45-year-old woman with primary B-cell lymphoma presents
with a palpable mass in the left breast. a Left cranio-caudal mammogram
demonstrates a high-density irregular mass with indistinct margins in the
medial left breast. b Ultrasound of the palpable mass demonstrates an
irregular hypoechoic mass with thin echogenic rim. c Axial PET/CT
shows homogeneous intense hypermetabolic activity within the mass.
No uptake is seen within normal appearing nodes in the left axilla
(not shown)
716 Insights Imaging (2014) 5:715–722
secondary BL tending to be smaller in size and more
often multiple [6, 8, 10, 11].
Ultrasound
The sonographic features of BL are variable. The most fre-
quent appearance of BL at ultrasound is of a hypoechoic,
irregular mass with indistinct margins (Fig. 1) [2, 8]. Interest-
ingly, in the series reported by Surov et al. [6], approximately
half of all cases demonstrated circumscribed margins. Hetero-
geneity of echo texture with hyperechoic regions, particularly
a thick echogenic rim, may be also seen. This predominantly
echogenic appearance was noted in approximately 23 % of
our cases (Figs. 2 and 4). Lesions mimicking cysts were seen
in four of our cases demonstrating marked hypoechogenicity
and posterior acoustic enhancement. BL masses may have no
internal vascularity seen on colour Doppler evaluation
in up to 55 % of cases [6]. However, Doppler analysis
was helpful to differentiate BL from a cyst in a case of
an anechoic mass (Fig. 3). No posterior acoustic phe-
nomenon was seen sonographically in 64 % of cases in
the series of Yang et al. [8]; however, Liberman et al.
[3] found posterior acoustic enhancement in 71 %
(5/7) of cases. Posterior acoustic shadowing is not a
feature of BL and this may be due to lack of desmoplastic
reaction [12]. Elastography was performed in one case from
our series. The mass was soft and was smaller on the
elastogram than on B-mode imaging suggestive of a benign
lesion. This is most likely due to the highly cellular nature
with lack of desmoplastic reaction in some types of
lymphoma. Three patients only had axillary adenopathy
identified sonographically in our series.
Fig. 2 A 74-year-old woman with primary large B cell breast lymphoma
presenting with a palpable mass in the left breast. a Cranio-caudal left
breast mammogram shows an isodense circumscribedmass (arrow) in the
medial left breast. b Ultrasound of the palpable mass demonstrates an
oval, circumscribed principally echogenic mass with an irregular shaped
central area of hypoechogenicity (arrows). c PET/CT shows two areas of
homogeneous hypermetabolic uptake in themedial left breast. No axillary
lymph node uptake was seen (not shown)
Fig. 3 A 67-year-old woman





detected new mass in the right
breast. a Right medio-lateral
oblique mammogram
demonstrates a lobulated
circumscribed isodense mass in
the upper right breast posterior
depth (arrow). b, c Ultrasound




vascularity on colour Doppler
evaluation indicating this is a
solid mass
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PET/CT
PET/CT has been shown to be useful in the staging of lym-
phoma with a sensitivity and specificity close to 100 % [13].
This technique is useful in assessment of treatment response
demonstrating residual metabolically active tumour and areas
of necrosis and fibrosis [13]. FDG PET can also be useful in
female patients with suspected lymphoma with dense breast
tissue which may obscure masses mammographically and on
CT [5, 13]. Uptake on PET is usually homogeneous and
intense with a reported average uptake value of 10.6 (Figs. 1
and 2) [7, 8] A “ring-shaped” peripheral pattern of hyperme-
tabolism is sometimes encountered, particularly in rapidly
growing or large tumours with areas of central necrosis or
haemorrhage. If there is diffuse lymphomatous infiltration,
then there may be associated hypermetabolic skin thickening
which can resemble inflammatory breast carcinoma [7].
Hypermetabolic lymphadenopathy in the axillary, hilar
regions or adenopathy elsewhere in the body may be a
prominent finding in secondary lymphoma. Primary breast
Fig. 4 A 72-year-old woman with
marginal zone B-cell lymphoma
with follicular colonisation presents
with developing focal asymmetry
within the right upper breast noted
on screening mammogram.
a. Ill-defined focal asymmetry
noted on the right medio-lateral
oblique screening mammogram
(arrow). b Ultrasound shows an
irregular principally hyperechoic
mass (arrows) extending to involve
the skin with central areas of
hypoechogenicity
Fig. 5 A 73-year-old man with a
history of CLL and a new
palpable mass in the left
breast with associated nipple
retraction. Biopsy showed
chronic lymphocytic leukaemia.
a Left breast medio-lateral
oblique and cranio-caudal
mammograms show an oval
circumscribed subareolar mass
with mild nipple retraction
(arrows). b, c Ultrasound
demonstrates an irregularly
shaped, hypoechoic mass with
angular margins and a thick
echogenic rim which shows
increased vascularity on colour
Doppler evaluation (arrows).
d Strain elastography (red
equating to hard) demonstrates a
hard mass which is significantly
larger on the elastogram. The ratio
of size was 1.99 between the
B-mode and strain image.
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cancers including inflammatory breast cancer and metastases,
especially from melanoma, may be difficult to differentiate
from haematopoietic neoplasms. There may be a false-
negative scan if the lesion is less than 1 cm [6].
Breast leukaemia
Breast involvement with leukaemia is rare, with fewer than
200 cases reported in the literature [14, 15]. Both myeloid
leukaemia and lymphocytic leukaemia involving the breast
have been described, with acute myeloid leukaemia (AML)
being most common [14]. Chronic myelogenous leukaemia
(CML) and CLL in the breast are exceedingly rare [14].
Leukaemic involvement of the breast may be seen either in
isolation or in the setting of widespread disease, and may be
seen in the setting of leukaemic relapse [14–17]. The median
age has been reported as 33 but with a wide age range of 1–
80 years [14]. Patients may present with unilateral or bilateral
breast masses with or without axillary adenopathy [14]. In our
series there were 8 patients with leukemic involvement of
the breast: 6 with chronic lymphocytic leukaemia and 2
with acute leukaemia. The unexpected predominance of
chronic over acute leukaemia in our series may be due to the
fact that in the clinical setting of acute leukaemia, breast
masses are presumed to represent systemic manifestation of
the disease and breast imaging and biopsy are not obtained if
masses resolved with treatment.
Mammography
Just over half of cases in one series had solitary lesions
identified with the median size of lesion being 3.5 cm (range,
0.6–11 cm) [14]. Breast leukaemia commonly presents
mammographically as a hyperdensemass withmicrolobulated
margins. Microcalcifications are rare. Diffuse infiltration
or architectural distortion may also be seen. In our
series, half of the patients with CLL (3/6) had a
mammographically detected mass; one case had a single
Fig. 6 A 76-year-old man with known CLL presents with new palpable
mass in the medial right breast which could not be included on a
mammogram. Biopsy showed CLL. a Fused PET/CT image shows a
hypermetabolic mass corresponding to the palpable mass in the medial
right breast. b Fused PET/CT image demonstrates hypermetabolic
axillary adenopathy (arrows). c Ultrasound shows a cluster of multiple
hypoechoic masses with microlobulated margins without increased
through transmission (arrows)
Fig. 7 An 83-year-old woman with known acute T-cell prolymphocytic
leukaemia presents with new palpable masses in the left breast. a Left
medio-lateral oblique and cranio-caudal diagnostic mammogram demon-
strates two areas of architectural distortion corresponding to the two
palpable masses (arrows). b Ultrasound shows ill-defined mixed
echogenic and hypoechoic mass (arrows). The other palpable mass had
a similar sonographic appearance (not shown)
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circumscribed mass (Fig. 5) and the other two had multiple
microlobulated masses. CLL was either mammographically
occult or was not included in the mammographic field of view
in the other three patients. Both of the patients with acute
leukaemic involvement of the breast in our series presented with
two or more masses in one or both breasts. Mammographically,
one case showed multiple areas of architectural distortion
(Fig. 7) and the other case showed multiple bilateral masses
with irregular shape and indistinct margins.
Ultrasound
Sonographically, breast leukaemia may present as single or
multiple heterogeneous hypoechoic masses. Of the cases
where margins were reported, the majority had indistinct or
microlobulated margins [14, 16]. Breast lesions were
sonographically visible in all six of our patients with CLL,
with all cases demonstrating hypoechoic masses; half of
which were circumscribed (Fig. 6) and the other half demon-
strating irregular shape and angular margins (Fig. 5). In-
creased vascularity was noted on colour Doppler interrogation
(Fig. 5). Breast elastography was performed in one case. The
tumour was hard on strain elastogram and was larger than on
the B-mode image, suspicious for malignancy (Fig. 5).
Axillary adenopathy was noted in two cases. In both patients
with acute leukaemia, masses demonstrated irregular shape
and non-circumscribed margins and heterogeneous
echogenicity with a significant echogenic component
(Fig. 7). No axillary adenopathy was seen in either patient
with acute leukaemia.
PET/CT
Ginat et al. [7] noted that leukaemic deposits in the breast
present as hypermetabolic breast masses on PET/CT. Hyper-
metabolic axillary adenopathy can also be appreciated as seen
in our two patients (Fig. 6).
Multiple myeloma
Multiple myeloma represents one of the plasma cell malig-
nancies, neoplasms with unabated proliferation of malignant
plasma cells [17]. Extramedullary plasmacytomas occur most
often in the head and neck region, but may also occur in many
other organs including skin, lungs, gastrointestinal tract and
bladder [9]. Similar to the other haematological diseases with
Fig. 8 A 57-year-old woman with known multiple myeloma of the
sacrum and multifocal involvement of the left breast and low axilla. a
Full-field digital medio-lateral oblique view of the left breast demon-
strates a round, circumscribed 1.9-cmmass (arrow) in the upper outer left
breast/low axilla corresponding to a palpable abnormality. Two additional
circumscribed masses were noted in the superior left breast posterior
depth (arrows). b Ultrasound of the palpable low axillary mass imaging
demonstrates a 2.0-cm heterogeneous mass with circumscribed margins
with only mild increase in vascularity on colour Doppler. c Ultrasound of
the mass at the 10 o’clock position of the left breast shows a
microlobulated principally echogenic mass with central area of
hypoechogenicity (arrow). The mass at the 9 o’clock position of the left
breast had a similar sonographic appearance (not shown). Ultrasound
guide core biopsy of all three lesions showed multiple myeloma. d
Minimal FDG uptake is noted within the left upper outer/low axillary
mass (arrow) on PET/CT
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mammary involvement, multiple myeloma in the breast is
very rare [9, 17, 18]. In the breast, myeloma most often
presents as an extramedullary manifestation in a patient with
known bone marrow involvement. Less often, breast involve-
ment with myeloma occurs in the absence of marrow disease,
referred to as breast plasmacytoma (BP). Primary BP is
exceedingly rare, accounting for less than 1 % of all
extramedullary plasmacytomas [19]. The mean age of
presentation is 55 years. Approximately 20 % of patients
who develop an isolated breast plasmacytoma later develop
multiple myeloma [9].
Mammography
The imaging appearance of myeloma in the breast is not well
documented in the literature, conveyed primarily through case
reports [20–24] and a recent review of the literature by Surov
et al. [20]. Primary BP demonstrates a similar imaging
appearance to cases of secondary extramedullary breast
involvement in patients with known bone marrow disease
[20]. A round, oval or lobulated mass is noted at mam-
mography in the majority of patients (Fig. 8). Margins are
well defined in approximately one-half of all cases. Less
common mammographic presentations include diffuse in-
volvement of the breast with an infiltrative mass or less
often a negative mammogram. Multiple masses are seen in
approximately one-third of cases (Fig. 8).
Ultrasound
At ultrasound, myeloma in the breast is most often homoge-
neously hypoechoic, much less likely hyperechoic or of mixed
echogenicity (Fig. 8) [20, 25]. Margins are well defined by
ultrasound in approximately one-half of all cases.
PET/CT
As with the other haematological malignancies, PET is useful
for staging purposes and assessment of treatment response. On
PET/CT, breast myeloma masses are often well defined and
demonstrate relatively low-grade FDG uptake (Fig. 8) [7].
Conclusions
Haematological malignancies of the breast are rare. They
demonstrate a variable imaging appearance but most fre-
quently manifest as lobular or irregular mass(es) with indistinct
margins at mammography and solid, irregular hypoechoic
masses at ultrasound. MRI typically shows plateau kinetics
and there is usually avid homogeneous hypermetabolism on
PET/CT with the noted exception of myeloma. In the
appropriate clinical context, these imaging findings should help
alert the radiologist to the correct diagnosis and ultimately
prevent unnecessary surgical treatment.
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